Chapter 13: Pregnancy Risk Factors & Fetal Assessment

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are taking a necessary and frankly intense plunge into a chapter that really defines safe practice in maternal child nursing.

It really does.

We're talking about identifying, assessing, and managing high -risk pregnancies.

For anyone entering this field, especially in the Canadian context, this stuff isn't optional.

No, it's absolutely foundational to reducing morbidity and mortality.

Right.

And our mission today for you, our listener, is to give you a shortcut to understanding this whole framework.

We're going to move systematically through the definitions, really get the impact of the social determinants of health.

Which are huge.

They're huge.

And then we'll walk through the technical assessment tools, you know, from first trimester screening all the way to third trimester surveillance.

We're defining what high -risk means, why it's growing, and what the nurse actually does about it.

Okay, so let's start with that definition.

High -risk can sound pretty broad.

Clinically, what actually puts a pregnancy in that category?

Well, we define it as any pregnancy where the life or health of the mother or the newborn is jeopardized.

And that could be by a medical disorder or social or even environmental factors that are either coincidental with the pregnancy or unique to it.

And a key point that nurses have to remember is that this high -risk status doesn't just vanish at delivery.

Right, that makes sense.

For the mother, the classification often extends to the entire poor perium.

That's that six -week recovery period.

And for the infant, of course, the consequences can last a lifetime.

So it frames the scope as being much, much wider than just the nine months.

And I think it's critical we acknowledge right away that getting this diagnosis, it's not just a clinical data point.

The sources really stress that this imposes a situational crisis on the patient and their family.

It absolutely does.

The moment that diagnosis is made, whether it's based on age or a pre -existing condition or some screening anomaly,

it introduces this profound fear and anxiety.

I can only imagine.

There's just deep uncertainty about the baby's health, about the birth itself.

And research suggests this heightened anxiety isn't just a side effect.

It can be so severe that it actually has a physical impact,

like contributing to increased rates of preterm birth.

The emotional burden itself becomes another risk factor we have to manage.

And when you look at the Canadian landscape specifically, this need for assessment is just growing.

We're seeing more patients with limited access to prenatal care.

All sorts of reasons.

Right, language barriers, no transport.

Maybe they've had negative, even discriminatory experiences with health care before.

And we also have that really sobering statistic.

Back in 2016, 15 % of pregnant patients in Canada were identifying mood disorders.

And that complexity demands a shift in approach.

We can't just treat the symptoms.

We have to understand the deep roots of risk, which takes us straight into the social context.

Okay, so let's talk about those root causes.

We're moving beyond just biology here and focusing on determinants of health, or DOH.

For a nursing student listening, why is this framework so foundational?

Why can't we just run a few blood tests and call it a day?

Because the DOH framework dictates health outcomes, sometimes even more powerfully than genetics alone.

Risk, so often, stems not from a single medical issue, but from these complex, persistent, and interwoven stressors.

Like what?

Think about chronic exposure to poverty, systemic racism, food and housing insecurity, oppression.

There's compelling evidence that links these sustained stressors to a state of chronic physiological activation, like your body is on constant high alert.

And that directly leads to?

Directly leads to adverse outcomes.

Preterm birth, low birth weight, chronic hypertension.

So if a nurse only focuses on managing, say, the blood pressure reading, without addressing the patient's unsafe housing or lack of nutrition, you're missing the single most critical opportunity for intervention.

Okay, so let's break down that detailed list of risk factors from the source material, but let's use that DOH lens.

Where should we start?

Let's start with the most intrinsic factor,

biology and genetics.

This covers things that are largely heritable, conditions like altered genes and existing genetic risk from family history, or issues like multiple pregnancy twins, triplets, even large fetal size or specific incompatibilities like ABO or RH factors.

Genetic risk assessment is key here, and it often happens very early to figure out the family's statistical risk before any symptoms even appear.

Okay, so that's the biology.

Now moving beyond the body itself, what about systemic factors like demographic and health care availability?

This is where you see some glaring disparities in Canada.

Patients in remote and rural areas have way fewer opportunities to access specialized care.

The cost and the logistics of travel and can be just enormous.

A huge barrier.

A huge barrier.

And socioeconomic status is also profoundly important.

Lower income patients are less likely to see specialists or might face these long waiting times for crucial appointments.

And then you have to consider the challenges

for recent immigrants'

language barriers, different cultural expectations, maybe a lack of knowledge about drug plans.

Or just finding a provider who is culturally competent.

Exactly.

And then the physical environment itself can bring these immediate tangible dangers that nurses have to actively screen for right at the intake interview.

Absolutely.

We're talking about environmental toxins.

Things like unsafe exposure to lead in older housing or contaminated fish with mercury or chemical exposures at work.

And there's a critical Canadian concern here too, right?

Yes, and it really speaks to a systemic failure.

It's the persistent presence of boil water advisories in many indigenous communities.

This prevents access to safe, clean drinking water, which is just a fundamental barrier to health, especially during pregnancy.

The nurse's role is to ask very specific targeted questions to identify these kinds of exposures.

The next factor, income and social status, feels like the master determinant.

It seems to influence access to almost everything else.

Income is, without a doubt, the linchpin.

It influences the quality of your diet, your education, your housing stability, the strength of your support networks.

And generally, lower income is associated with increased medical complications.

But we need to be careful not to just focus on deficits.

Yes, that's so important.

The research with young indigenous patients, for instance, found that successfully navigating the challenge of pregnancy against really significant odds was a source of profound pride.

A good nursing assessment identifies not just the barriers, but also these crucial sources of resilience and strength.

So how does culture interact with outcomes, especially when we look at health disparities?

Well, the data is very clear.

It demonstrates higher infant mortality rates among indigenous people in Canada compared to the general population.

And this is tragically compounded by reported negative health care experiences, including racism and discrimination.

Which would obviously lead to a reluctance to seek care.

An understandable reluctance, yes.

And this avoidance means conditions that could be managed early, like gestational hypertension, are often left unmanaged until they become a full -blown crisis.

Plus, different cultural beliefs might dictate a different approach to prenatal care than the standard Western model.

So we need sensitive, culturally competent adjustments.

Okay, shifting to daily life.

Employment and working hazards.

I'm guessing this is more than just manual labor.

That's correct.

Occupational hazards are broad.

They can be chemical, physical, biological, and psychological.

So high risk factors could be a physically demanding job, prolonged standing exposure to industrial fumes, but also shift work, which disrupts your circadian rhythm.

Even a high stress, psychologically demanding role can be classified as a hazard.

And finally, let's cover personal health practices and coping skills.

This is where lifestyle factors really come into play.

Right.

So start with substance use.

Smoking, even just passive exposure, is directly linked to intraderine growth restriction, IUGR, preterm birth, low birth weight.

And alcohol.

Alcohol consumption, even in small amounts, can result in fetal alcohol spectrum disorders.

Then there's medication misuse.

Nutritional status is also vital, and deficiencies are unfortunately common in vulnerable populations.

And you have to include a seemingly unrelated factor, dental hygiene.

It's a classic example of systemic inflammation.

Periodontal disease, which is chronic gum infection,

is a significant and independently verified risk factor.

It substantially increases the likelihood of preterm birth and low birth weight.

It mandates screening and referral.

You have to emphasize to your patient that pregnancy is not a time to avoid the dentist.

So we've laid out this really comprehensive DOH framework.

How do we actually put it into practice?

How does a nurse operationalize this?

Exactly.

The nurse has to use structured, non -judgmental questions to assess the patient's database.

We're not just having a chat.

We are systematically collecting data on specific DOH barriers.

So you're asking about things like housing stability.

Yes.

Or potential environmental exposures like mold or lead paint.

Or asking if they were worried food would run out in the last month, a key marker for food insecurity.

We look at transportation barriers.

Can they physically get to their appointments?

Are there threats of utility shutoffs?

These are all quantifiable stressors.

And the source also highlights using structured screening tools for personal safety.

That's a highly sensitive area, so structure is absolutely essential.

Nurses often use tools where questions about physical or emotional abuse get a numerical value.

A score over 10, for instance, indicates a positive screen for potential intimate partner violence.

So the system ensures that when a barrier is found, the nurse immediately has the responsibility and the knowledge to connect that patient with the community resources, hopefully mitigating a major risk factor.

That DOH Foundation really sets the stage for understanding the clinical risk.

So globally, maternal deaths are still dominated by things like hemorrhage and infection.

But in Canada, the profile is different.

What are the leading causes of maternal mortality here?

Our leading causes really reflect a system that has, for the most part,

controlled massive infection and hemorrhage.

We struggle more with the secondary complications of chronic illness.

So our leading causes are hypertensive disorders, like preeclampsia, pulmonary embolism, hemorrhage is still on the list, and critically, mental illness.

And what are the numbers like?

Statistics Canada put the maternal mortality rate at 8 .3 per 100 ,000 live births in 2018.

The crucial takeaway for you as a nurse is that a high proportion of these deaths are still preventable.

How so?

Largely by ensuring the consistent and regular use of high quality prenatal care, especially for those high risk populations.

Okay, let's pivot to some specific pregnancy complications.

These really highlight the complexity of fetal fluid dynamics.

Let's start with polyhydramnios, too much amniotic fluid.

Polyhydramnios often tells us that the fetus isn't swallowing enough fluid.

The main risk factors are poorly controlled diabetes in the mother and fetal congenital anomalies, especially ones that affect the GI tract or the central nervous system, which would impair that swallowing reflex.

So the nurse recognizes this as a sign of a potential underlying issue.

And what about the opposite?

Oligohydramnios, too little fluid.

Oligohydramnios suggest the fetus isn't producing enough urine, or the placenta isn't doing its job properly.

This is strongly associated with conditions that impair fetal urine output, like renal agenesis, the failure of the kidneys to develop.

Potter syndrome.

Exactly.

It's also linked to issues that limit blood flow to the kidneys.

So things like utero placental insufficiency, severe IUGR, or maternal hypertensive disorders.

Oligohydramnios is critical because that lack of fluid significantly increases the risk of the umbilical cord being compressed during labor.

We mentioned intrauter growth restriction, or IUGR.

What specific maternal and fetal factors put a baby at risk being significantly small?

Oh, the maternal risk factors are extensive.

Chronic hypertensive disorders, pregestational diabetes, autoimmune disease, and significantly substance use, especially tobacco, which causes placental vasoconstriction.

And fetal causes.

Fetal causes would be things like severe genetic disorders, exposure to teratogens early on, or viral infections.

If you recognize these maternal factors early, it mandates enhanced surveillance, often starting in the second trimester with ultrasound.

Let's talk more about mental health concerns.

We mentioned that 15 % incidence of mood disorders.

Why are these so detrimental and what does a nurse need to do right away?

The effects just cascade across the whole perinatal experience.

Maternal depression is linked to decreased self -care, increased smoking, IUGR, higher rates of preterm labor,

and significantly lower rates of breastfeeding.

And crucially, the infant is sensitive to the mother's emotional state, which can lead to difficulty bonding.

So the response has to be multifaceted.

Exactly.

Interprofessional collaboration is paramount.

We have to prioritize early and consistent screening for both parents.

The father or partner's mental health is also critical.

We use tools like the Edinburgh Postnatal Depression Scale, the EPDS, to identify distress early and get them referred to specialized services quickly.

The sources specifically outline the British Columbia Guiding Principles for Care.

These seem like core tenets for nursing practice.

They are.

These principles guide us on how to provide humane, therapeutic care.

First,

recognize the high prevalence.

Up to one in five patients are at risk.

Second, the fundamental principle is to provide services that preserve the mother -infant diet whenever it's safely possible.

Because separation can make it worse.

That can compound the trauma.

Third, care has to be in a fragile self -esteem.

And finally, always emphasize a collaborative team approach, linking them with community services for ongoing support.

Okay.

Next up, a global public health issue that needs constant assessment.

Intimate Partner Violence, or IPV.

The stats are harrowing.

One in three women experience abuse in her lifetime.

Why is pregnancy such a high -risk time?

For some, pregnancy can be a trigger for the abuser escalating the violence.

IPV during pregnancy significantly increases the risk for physical trauma, which can lead to placental abruption, hemorrhage, preterm birth, low birth weight, just a whole host of terrible outcomes.

And patients experiencing violence are less likely to seek out regular prenatal care, which just compounds all those risks.

So for the nurse, what's the rule?

The rule is simple.

Assess at every single prenatal visit.

And then again, upon admission in labor.

Routine assessment is mandatory.

And since abuse is all about power and control, how should a nurse intervene to support a victim?

The intervention has to focus on restoring control to the patient.

Your primary role is providing support, listening, and offering information about auctions and resources so they can make their own decisions safely.

Research has found that providing specific information on fetal development can be really supportive as it reinforces that mother -fetus connection.

So you never pressure them.

Never pressure them to leave.

You support their choices.

Okay, finally in this section, let's touch on infant morbidity and mortality.

Leading causes are things like preterm birth, low birth weight.

So why, despite Canada having universal health care, do we still see higher death rates linked to lower socioeconomic status?

Because universal health care primarily addresses the cost of treatment, not the cost of accessing care or the social determinants of health.

It doesn't eliminate financial, educational, sociocultural, and logistical barriers.

If a patient can't afford the bus fare to get to the clinic, the care is inaccessible.

To truly reduce morbidity, you need high -quality care and advanced tech, yes, but they have to be delivered in an accessible, equitable way that addresses those foundational DOH issues.

Okay, so we've established the risk profile.

Now we have to assess it.

The primary goal of antepartum testing, especially in the first and second trimesters, is all about being proactive.

Absolutely.

It's about early detection of fetal compromise, ideally before intrauterine asphyxia can happen.

The key question is always,

is the fetus suffering from a chronic problem that needs intervention?

And this is where we need to be really clear about the difference between screening and diagnosis.

Exactly.

Screening should be offered to all pregnant patients, regardless of age.

That's a big shift from the old practice of only testing those over 35.

Screening identifies your risk level.

Diagnostic testing, like an amnio, gives you a definitive answer.

Let's start with the non -invasive screening in the first trimester, enhanced first trimester screening, or EFTS.

Right.

This is typically done between 11 and 14 weeks.

EFTS combines an ultrasound with maternal blood markers.

The first component is the neutral translucency, or NT, ultrasound.

And that's the fluid at the back of the baby's neck.

That's right.

The fluid -filled area in the nape of the fetal neck.

If the fluid collection is greater than three millimeters, it's highly indicative of genetic disorders like Trisomy 21 or 18, or other major physical anomalies.

And if it's over 3 .5 millimeters, that significantly increases the risk of a congenital heart defect, which immediately flags the need for a fetal echocardiogram later on.

So what are the biochemical markers involved in EFTS?

What pattern are we looking for in, say, Trisomy 21?

We measure two specific serum markers.

The first is PPA, and the second is free beta -HCG.

The mnemonic for Trisomy 21 is PPA is low, and beta -HCG is high.

Low PPA suggests a poorly functioning placenta.

When you combine the NT measurement and these markers, the detection rate for Down syndrome is pretty impressive, between 78 and 91%.

Okay.

Next, we have the traditional second trimester serum screening, known for MSAFP.

Right.

Maternal serum alpha -fetoprotein.

This primarily screens for open neural tube defects like spina bifida.

AFP is a protein from the fetal liver, and high levels in the mother serum suggest it's leaking from an open defect.

But ultrasound is now the primary tool for that.

Yes.

The SOGC recommends a detailed ultrasound as the primary screen for NTDs.

But MSAFP is still used, especially if a patient presents too late for that first trimester window.

And conversely, abnormally low levels of MSAP are associated with

Alright, now for the real game changer.

Self -re -DNA screening, or CFDNA, also called NIPT.

This uses just a simple maternal blood sample.

Why is this so revolutionary?

It is a huge technological leap.

It utilizes tiny fragments of DNA from both the mother and the fetus that are just circulating in the maternal plasma.

The test can accurately predict fetal status by analyzing the proportion of these fragments.

So if you see too much DNA from a

Exactly.

If we see an excess ratio of DNA from chromosome 21, 18, or 13, it suggests the presence of trisomy.

The detection rate is a sounding over 99 % for trisomies 21 and 18.

And it can be done optimally around 10 to 12 weeks.

So given that accuracy, is CFDNA considered a final diagnosis?

No.

And this is the crucial nursing point you have to counsel your patient on.

CFDNA is still a screening test.

Even a positive result, which is highly predictive, requires diagnostic confirmation with an amniocentesis or CVS to confirm the fetal karyotype.

So you have to be very clear about that distinction.

Very clear.

You also have to mention its limitations.

Cost coverage is variable across Canada.

It's less sensitive in obese patients because of a lower fetal fraction.

And it's not generally recommended yet for multi -fetal pregnancies.

Let's move to ultrasound technology.

It's often called the most valuable diagnostic and surveillance tool in obstetrics.

It really is.

It's based on sound waves with frequencies higher than human hearing.

The transducer emits sound beams that strike objects, the baby, the placenta, and then an echo returns.

The machine then interprets that reflection based on tissue density.

So fluid is black and bone is bright.

Exactly.

Fluid is anechoic, or black, and dense bone is hyperechoic, or bright white.

And we use two main procedures,

abdominal and transvaginal.

What are the key differences?

Abdominal ultrasound is standard after the first trimester.

Early on, the patient needs a full bladder to push the uterus up for better visualization.

Transvaginal, where the probe is inserted into the vagina, gives much greater resolution of pelvic anatomy.

It's great for early diagnosis.

You don't need a full bladder and it's often preferred for obese patients.

Let's walk through the trimester -specific uses.

What's the focus in the first trimester?

In the first trimester, the priority is confirming viability.

So seeing the heartbeat determining gestational age, where crown rump length is the most accurate method, and ruling out things like an ectopic pregnancy.

Then in the second trimester, the focus shifts heavily to anatomy and growth.

Precisely.

The SOGC recommends a routine detailed anatomical scan between 18 and 22 weeks.

This is the big one where they meticulously check for fetal anomalies, NTDs, heart defects, renal issues.

And detecting an anomaly here is critical because it influences the entire birth plan.

And by the third trimester, it's mostly for surveillance.

Right.

It's mainly used to confirm viability, assess growth, either restriction or potential macrosomia, and to perform the biophysical profile, which we'll get to.

It's also vital for checking on the placenta, especially looking for things like placenta previa.

You mentioned IUGR and macrosomia.

How does ultrasound help differentiate between growth problems?

It allows us to

a baby that's small because the dates are wrong versus true pathological growth restriction.

We look for two patterns.

Symmetrical IUGR means the fetus is small in all parameters, head, abdomen, legs.

This suggests a chronic long -standing insult from early ingestation, like a genetic issue or infection.

And the prognosis is often poorer.

Often, yes.

Asymmetrical IUGR implies an acute, late -occurring deprivation, usually from placental insufficiency caused by something like maternal hypertension.

Here, the fetus preserves blood flow to the brain at the expense of body fat and the liver.

The head is normal -sized, but the abdomen is small.

And that clinical distinction is crucial for prognosis and planning.

We see a similar thing with macrosomia, a baby over 4 ,000 grams.

Correct.

The patterns differ.

Macrosomia, in an infant of a diabetic mother, is typically asymmetrical.

They have excessive fat in the but a normal head, which puts them at high risk for shoulder dystocia.

If the mother is obese without glucose issues, the macrosomia tends to be symmetrical big all over.

This distinction really guides the birth management plan.

So what's the specific nursing role in all of this?

This is often the most exciting and anxiety -provoking part of the patient's journey.

Our primary role is comprehensive counseling and education to allay that anxiety.

The tests are ordered because an anomaly is suspected, which causes enormous stress.

We have to provide accurate information about the procedure and the limitations of the findings.

And there's the controversy of non -medical use, the keepsake ultrasounds.

Yes.

And we must strictly adhere to the SOGC and Canadian Association of Radiologists policy on this.

It strongly advises against non -medical use because it exposes the fetus to sound waves without medical indication, and risks either missing a true abnormality, giving false reassurance, or discovering one outside of a proper medical counseling setting.

Okay, let's transition to biochemical assessment.

These involve getting biological specimens, sometimes invasively.

We can start with the non -invasive Coombs test.

The indirect Coombs test screens for RH incompatibility.

We're checking the mother's blood for antibodies that might attack the fetus's red blood cells.

Historically, a maternal titer over 1 .8 was a significant risk.

Today, this is largely replaced by non -invasive middle cerebral artery Doppler studies to assess for fetal anemia directly.

But the primary diagnostic technique remains amniocentesis.

What are the key indications?

Amniocentesis is used for three main things.

Genetic diagnosis or karyotyping, assessment of pulmonary maturity, and rarely diagnosis of fetal hemolytic disease.

For genetics, it's offered for patients over 40 or those whose screening tests indicate high risk.

The fluid is cultured to allow for karyotyping.

And if the procedure is done later in the third trimester, we're looking specifically for fetal maturity.

Yes, specifically lung maturity.

The key measure is the lecithins -fingomyelin, or LS, ratio.

These are components of surfactant, which lets the baby's lungs expand.

An LS ratio of 2 .1, along with the presence of PG, indicates lung maturity and a lower risk of respiratory distress syndrome.

What are the risks, and what is the crucial safety alert for nurses managing this procedure?

Complications are rare, less than 1%, thanks to ultrasound guidance.

But the nursing safety alert is absolutely non -negotiable.

Because of the risk of feto -maternal hemorrhage, the mixing of maternal and fetal blood, we must administer ReOD immunoglobulin to all Rh -negative patients immediately afterward to prevent isoimmunization.

The alternative to an amnio is chorionic villus sampling, or CVS, which offers an earlier diagnosis.

CVS is performed much earlier, between 10 and 13 weeks.

It involves removing a small tissue specimen from the fetal placenta.

Since this tissue originates from the zygote, it reflects the genetic makeup of the fetus.

What's the main clinical trade -off between CVS and amniocentesis?

Well, besides the timing, the main trade -off is that CVS can't be used for maternal serum marker screening or assessing lung maturity because you're not getting any amniotic fluid.

It's purely for genetic diagnosis.

And this whole area of prenatal diagnosis leads directly into the ethics of fetal rights.

The nurse is often the one dealing with the immediate emotional fallout.

It's a profound ethical challenge.

Since these tests are often used to diagnose fetal defects for which no treatment exists, the possibility of elective termination is intrinsically linked to their performance.

The nurse has to approach this with immense sensitivity, recognizing the huge ethical and moral weight this carries for the patient.

Our job is to provide facts, not judgment.

And briefly, we have percutaneous umbilical blood sampling or PBS.

PBS is direct access to the fetal circulation through the umbilical vein.

It used to be used for rapid karyotyping or fetal blood transfusions.

But due to its risk, it's largely been replaced by safer methods.

Today, it's mainly reserved for really complex genetic issues like clarifying mosaic results from other tests or assessing severe fetal anemia.

We've moved past the mid -pregnancy diagnosis phase.

The third trimester marks a crucial shift in focus.

The goal is no longer diagnosing anomalies.

No, the goal now is determining if the intruder and environment is still supportive enough to let the fetus grow safely.

The underlying concern is a loss of placental function, which leads to chronic fetal hypoxia.

So the clinical urgency really ramps up here.

It does.

The testing we use now focuses entirely on physiological responses, how the fetus is compensating for declining oxygen.

For patients with high -risk conditions like hypertension or diabetes, we have to determine if the placental reserve is failing and, if so, time the birth before intrauterine efficacy occurs.

Let's start with the simplest, most non -invasive assessment available.

Fetal movement counting or KIT counts.

This is a fundamental patient education piece.

Fetal movement is a robust, reassuring sign of fetal central nervous system health.

Decreased movement is the earliest, most alarming signal of decreased placental perfusion.

What's the technique?

It's simple.

The patient should count six movements, kicks, rolls, flutters within a two -hour period.

If they do not get six movements in two hours, they must immediately call their provider or go in for assessment.

The fetal movement algorithm in the source material clearly maps up the next steps.

It does.

For patients without risk factors, if movement decreases and they count less than six, they proceed to a non -stress test, or NST.

For patients with established risk factors, they do daily counting.

If their counts are low, they move immediately to the NST, and if that's abnormal, on to a biophysical profile, or BPP.

Okay, so next is the technological surveillance.

Electronic fetal monitoring, or EFM.

The core principle here is that FHR variability indicates an intact nervous pathway.

Exactly.

It's all based on fetal physiology.

When hypoxia begins, the fetus shunts blood to the vital organs, the brain, heart, and adrenals.

If the central nervous system fails to keep up, you see characteristic FHR patterns, most notably a loss of baseline variability.

And the non -stress test, or NST, is the most widely applied technique.

It's based on FHR acceleration with movement.

How's it done?

The patient is placed in a reclining position with a slight left hilt to optimize uterine perfusion.

The FHR and uterine activity are recorded.

The test usually lasts 20 minutes, but can be extended if the fetus is sleeping.

And the results are classified as normal, atypical, or abnormal.

Right.

A normal or reactive NST for a term fetus requires a baseline FHR between 110 and 160, moderate variability, and at least two FHR accelerations of 15 beats for 15 seconds, the 15 by 15 rule.

A normal tracing is generally very predictive of a good outcome for one week.

And what defines an abnormal NST, signaling the need for intervention?

An abnormal or non -reactive tracing shows minimal or absent variability for 80 minutes or more, or significant recurrent decelerations.

An abnormal result means the fetus lacks reserve and needs immediate further assessment, usually with a BPP.

The contraction stress test, or CST, provides an earlier warning by evaluating the fetal response to induced contractions.

How does that work?

The mechanism is simple.

Uterine contractions temporarily compress blood flow into the placenta.

If the placenta is healthy, the fetus handles it easily.

If the placenta is already struggling, that brief dip in blood flow will induce hypoxia and cause a late deceleration in the FHR.

So given the risks, there are crucial contraindications for the CST.

A nurse has to memorize these.

You cannot do a CST if the patient shouldn't give birth vaginally at that time.

So that includes preterm labor, placenta previa, multiple gestation, or a previous classic uterine incision because of the risk of rupture.

And you can induce contractions in two ways.

Yes.

Nipple -stimulated is tried first as it releases endogenous oxytocin.

If that fails, the nurse starts a slow IV infusion of oxytocin, titrating it very slowly to prevent hyperstimulation.

How do you interpret the results?

A negative CST is the goal.

No late decelerations.

This strongly suggests the fetus has enough reserve to tolerate labor.

A positive CST is highly concerning.

It means repetitive late decelerations are happening.

This indicates low fetal reserve and often necessitates a decision on an expedited birth.

Okay.

Moving on to the biophysical profile, or BPP.

This is essentially a detailed physiological physical exam of the fetus.

It is.

The BPP is a critical noninvasive assessment combining acute and chronic markers of fetal health.

The idea is that the central nervous system controls these parameters, and if the fetus is becoming hypoxemic, the CNS function will be impaired in a specific sequence.

So let's detail the five key variables that are scored.

Each variable gets a score of two for normal or zero for abnormal.

The first three assess acute CNS function,

fetal breathing movements, fetal movements, and fetal tone.

The fourth assesses the chronic environment,

amniotic fluid volume or AFV, and the fifth is the acute cardiac response, the non -stress test.

And the scoring system is used to guide management.

What does the BPP management table tell us?

It gives us the action plan.

A score of eight to 10 is normal, very low risk.

A score of six is equivocal or questionable.

If the fluid volume is normal, you retest in 24 hours.

But if the fluid is low oligohydraminoids, birth is generally indicated for a term fetus.

And any score less than six is abnormal and requires immediate intervention, often delivery.

And that amniotic fluid volume component is a reflection of the chronic environment.

Right.

Oligohydraminoids, or decreased fluid, is a chronic sign of poor placental function because reduced blood flow leads to decreased kidney perfusion and less urine output.

Polyhydraminoids, or increased fluid, is often associated with GI or CNS abnormalities that stop the fetus from swallowing effectively.

Finally, we have Doppler blood flow analysis.

Doppler uses systolic -diastolic ratios, usually on the umbilical artery, to tell us how hard the heart is working to overcome placental resistance.

The key pathological finding is absent or reversed flow during diastole in the umbilical artery.

This indicates severely restricted blood flow and massive utero placental resistance.

It's strongly linked to severe IUGR.

We've covered some extensive technical ground, but the reality is that the nurse is the constant presence here.

The nursing role is paramount as an expert educator, a coordinator, and a critical supporter.

We have to move beyond the technical skills and recognize the profound psychosocial impact.

A high -risk diagnosis often imposes guilt and a deep sense of failure on the patient.

They feel vulnerable, anxious, and judged, and their perception of the risk is often very different from the provider's clinical assessment.

So how does a nurse address that difference?

The nurse has to help the patient explore their understanding of the risk, and if hospitalization is necessary, that just adds enormous stress.

Loneliness, separation from family, a profound feeling of powerlessness.

This high -risk state can also delay preparation for the baby, which impacts maternal attachment.

So what are the actionable specific nursing interventions for those psychological needs?

First, we need to help patients maintain control and identity outside of that high -risk label.

So encouraging normal life activities where possible hobbies, social contact.

Second, we must provide frank and consistent information about the baby's health.

Research found that patients who got direct, consistent, honest information felt significantly more supported and less anxious.

So no vague platitudes?

None.

If the NST is equivocal, you explain why it's equivocal and what the next specific steps are.

And third, you actively frame the relationship as a collaboration.

You explain, we are a team working together to manage this.

This helps reduce their sense of powerlessness and validates their identity beyond just being a high -risk patient.

That reframing seems like the ultimate goal of high -risk nursing.

It's acknowledging the science while affirming the humanity of the patient.

It is.

The nurse is the one who humanizes the technology.

This has been an incredibly detailed deep dive into the complexities of assessing risk in pregnancy.

Let me finish up with the essential nursing takeaways for anyone entering maternal child practice in Canada.

Okay, the key priorities are fourfold.

First, remember that high risk is fundamentally multifactorial.

You need an assessment framework that goes beyond biophysics and integrates the social determinants of health income, culture, environment as crucial, actionable risk factors.

Second, the testing strategy.

Non -invasive screening, like CFDNA and EFTS, must be offered to all patients.

But invasive testing, like amnio and CVS, is reserved strictly for diagnostic confirmation when a screening result is positive.

You have to counsel your patient clearly on that screening versus diagnosis distinction.

Third, the final weeks of pregnancy.

Third trimester surveillance, NSTs, CSTs, and BPPs is crucial for assessing acute fetal well -being.

You use those established physiological principles and standardized scoring systems to time interventions and prevent intrauterine asphyxia.

And finally, the critical nursing priority that ties all this technical knowledge together.

The active management of the psychosocial needs of the high -risk patient is essential.

Anxiety, vulnerability, feelings of powerlessness, these are clinical concerns that you have to actively manage with targeted interventions aimed at providing control, consistent information, and collaborative support.

While technology gives us these incredibly powerful tools for detection and surveillance, the ultimate measure of success in high -risk care is ensuring that the psychological and social supports we provide are robust enough to match that clinical intensity.

It's about validating the patient's identity beyond the label of high -risk.

That is where true, family -centered, trauma -informed nursing begins.

And that's something for you to think about as you move into clinical practice.